Die Grafik zeigt die prognostizierten Quartalsgewinne (Bereinigter Gewinn pro Aktie, EPS) und die tatsächlich erzielten Gewinne (grün: Analystenschätzungen übertroffen, rot: Analystenschätzungen verfehlt) für den ausgewählten Zeitraum.
Umsatz (USD)
Schätzung
Umsatz
Die Grafik zeigt die prognostizierten Quartalsumsätze und die tatsächlich erzielten Umsätze (grün: Analystenschätzungen übertroffen, rot: Analystenschätzungen verfehlt) für den ausgewählten Zeitraum.
Güte der Analystenschätzungen – EPS (aktueller Zeitraum)
Quartal / Datum
EPS (USD)
Schätzung (USD)
Abweichung
Quartal / Datum
Umsatz (Mio USD)
Schätzung (Mio USD)
Abweichung
Revisionen der Gewinnschätzungen
EPS-Schätzungen für die Geschäftsjahre
2026, 2027, 2028.
Increasing manufacturing activity, technological advancements and strategic acquisitions are supporting the near-term outlook of the Zacks Manufacturing - General Industrial industry. PH, IEX, CR and AIT are some promising stocks in the industry.
NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX CORPORATION (NYSE:IEX) today announced that its Board of Directors has approved a regular quarterly cash dividend of $0.73 per common share. This dividend will be paid January 27, 2027 to shareholders of record as of January 13, 2027. This dividend represents the company's 129th consecutive regular quarterly cash dividend payment.About IDEXIDEX Corporation (NYSE: IEX), a global engineered products company, is comprised of three primary business segments –.
The headline numbers for Idex (IEX) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Idex (IEX) came out with quarterly earnings of $2.33 per share, beating the Zacks Consensus Estimate of $2.23 per share. This compares to earnings of $2.03 per share a year ago.
NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX Corporation (NYSE: IEX) today announced its financial results for the three-month period ended September 30, 2026. “We are pleased to report another strong quarter, with results ahead of our expectations. This quarter, we delivered both record sales and adjusted EPS while expanding margins and booked nearly $1 billion in orders. Advantaged markets and larger acquired businesses are driving this performance, and momentum is broadening across the rest of th.
IEX heads into its Q3 2026 earnings report with expected revenue growth from Health & Science Technologies and acquisitions, but rising costs may pressure profits.
Portfolios
0
Zum Anlegen oder Bearbeiten von Portfolios müssen Sie sich anmelden oder einen Account erstellen.
Aktuelle Aktie in ein Portfolio speichern oder neues Portfolio anlegen: